MedPath

Transversalis Fascia Plane Block Versus Intrathecal Morphine for Postoperative Analgesia in Total Abdominal Hysterectomy

Not Applicable
Recruiting
Conditions
Intrathecal Morphine
Postoperative Analgesia
Total Abdominal Hysterectomy
Transversalis Fascia Plane Block
Interventions
Other: Transversalis fascia plane block
Registration Number
NCT07201272
Lead Sponsor
Tanta University
Brief Summary

This study aims to compare the ultrasound-guided transversalis fascia plane (TFP) block and intrathecal morphine for postoperative analgesia in patients undergoing total abdominal hysterectomy (TAH).

Detailed Description

Total abdominal hysterectomy (TAH) is a commonly performed major surgical procedure that results in substantial postoperative pain and discomfort. Postoperative pain, if not treated promptly, can impair the patient's ability to ambulate which may lead to adverse effects such as thromboembolism, myocardial ischemia, and arrhythmia.

Intrathecal opioids are synergistic with local anesthetics and intensify the sensory block without increasing the sympathetic block. Morphine, which is relatively less hydrophobic than other opioids, has a longer residence time in the cerebrospinal fluid and therefore may reach rostral sites over a longer period than other opioids.

Ultrasound-guided interfascial plane blocks are often used in multimodal analgesia regimens. Local anaesthetic injection into the transversalis fascia plane (TFP) anesthetizes the proximal branches of T12 and L1 which targeted in the plane between the transversus abdominis muscle and the transversalis fascia.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Age from 18 to 65 years.
  • American Society of Anesthesiology (ASA) physical status I-II.
  • Women undergoing total abdominal hysterectomy (TAH) under spinal anesthesia.
Exclusion Criteria
  • History of allergies to local anesthetics.
  • Local infection at the site of injection.
  • Bleeding disorders.
  • History of chronic use of analgesic.
  • Physical or mental conditions.
  • Hepatic, renal or cardiac disease.
  • Contraindication to spinal anesthesia.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
TFP groupTransversalis fascia plane blockPatients will receive spinal anesthesia (using 3.5 mL of hyperbaric bupivacaine 0.5%) with bilateral transversalis fascia plane (TFP) block (using 20 mL of bupivacaine 0.25%) at the end of surgery.
IM groupMorphinePatients will receive spinal anesthesia (using 3 mL of hyperbaric bupivacaine 0.5%) + (75 µg morphine diluted in 0.5ml saline) with sham block at the end of surgery.
Primary Outcome Measures
NameTimeMethod
Time to the 1st rescue analgesia24 hours postoperatively

Time to the first request for the rescue analgesia (time from the end of surgery to first dose of morphine administrated).

Secondary Outcome Measures
NameTimeMethod
Total morphine consumption24 hours postoperatively

Rescue analgesia of morphine will be given as 3 mg bolus if the numeric rating scale (NRS)\> 3 to be repeated after 30 min if pain persists until the NRS \< 4.

Degree of pain24 hours postoperatively

Each patient will be instructed about postoperative pain assessment with the numeric rating scale (NRS). NRS (0 represents "no pain" while 10 represents "the worst pain imaginable"). NRS will be assessed at post-anesthesia care unit (PACU), 2, 4, 6, 8, 12, 18, and 24 h postoperatively.

Incidence of adverse events24 hours postoperatively

Incidence of adverse events such as bradycardia, hypotension, pruritis, nausea, vomiting, respiratory depression, or any other complication will be recorded.

Trial Locations

Locations (1)

Tanta University

🇪🇬

Tanta, Egypt

Tanta University
🇪🇬Tanta, Egypt
Mohammed S Elsharkawy, MD
Contact
00201148207870
mselsharkawy@med.tanta.edu.eg

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.